- Launched in 2019
- Listed in PubMed and freely available via PubMed Central
- Indexed in the Directory of Open Access Journals (DOAJ), Web of Science and Emerging Sources Citation Index (ESCI)
- Rapid publication
- Rigorous peer review
Submit your manuscript today at https://mc.manuscriptcentral.com/cmg
Please see the Submission Guidelines tab for more information on how to submit your article to the journal.
Open access article processing charge (APC) information
The APC for this journal is currently $2000 USD.
The article processing charge (APC) is payable only if your article is accepted after peer review, before it is published. The APC is subject to taxes where applicable. Tax-exempt status can be indicated by providing appropriate registration numbers when payment is requested. Please see further details here
Please direct any queries to email@example.com
Therapeutic Advances in Gastrointestinal Endoscopy is an open-access, peer-reviewed journal delivering the highest quality original research articles, reviews, and scholarly comments on pioneering efforts and innovative studies across all areas of gastrointestinal endoscopy with a strong focus on diagnostic and therapeutic advances. The journal is aimed at an international audience of endoscopists, clinicians, surgeons and researchers in endoscopy and related disciplines, providing an online forum for rapid dissemination of recent research and perspectives in this area.
Original research manuscripts may include laboratory, animal or human/clinical studies – all phases. Letters to the Editor and Case Reports will also be considered.
Review articles include expert opinion/perspective reviews, narrative reviews and therapeutic area reviews. Systematic reviews, meta-analyses, postmarketing and health economic and pharmacoeconomic reviews are also welcomed. The appropriate EQUATOR Network reporting guidelines should be followed (e.g. CONSORT for randomized, controlled trials and PRISMA for systematic reviews/meta-analyses). The journal endorses the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first patient enrolment. However, consistent with the AllTrials campaign, retrospectively registered trials will be considered if the justification for late registration is acceptable.
The journal adheres to a blind review process in which the reviewer's name is routinely withheld from the author unless the reviewer requests a preference for their identity to be revealed. Manuscripts are reviewed by at least two referees; a first editorial decision is generally reached within 3 weeks of Acceptance.
|Pradeed Bhandari||Queen Alexandra Hospital, Portsmouth, UK|
|Guido Costamagna||Università Cattolica del Sacro Cuore, Roma, Italy|
|José Cotter||University of Minho, Braga, Portugal|
|Simon M. Everett||Spire Leeds Hospital, Leeds,UK|
|Ian Gralnek||Emek Medical Center, Afula, Israel|
|Tomas Hucl||Institute for Clinical and Experimental Medicine, Prague, Czech Republic|
|Martin Keuchel||University of Hamburg, Hamburg Germany|
|Anastasios Koulaouzidis||The Royal Infirmary of Edinburgh, Edinburgh, UK|
|Gianpiero Manes||G. Salvini Hospital, Milano, Italy|
|Sara Monteiro||Alto Ave Hospital Center Creixomil, Guimarães, Portugal|
|Helmut Neumann||University Medical Center Mainz, Mainz, Germany|
|Kofi Oppong||Freeman Hospital, Newcastle upon Tyne, UK|
|Oliver Pech||Krankenhaus Barmherzige Brüder, Regensburg, Germany|
|Marco Pennazio||San Giovanni Battista University Teaching Hospital, Turin, Italy|
|Jan-Werner Poley||Erasmus MC, University Medical Center Rotterdam, the Netherlands|
|Gabriel Rahmi||Hôpital Européen Georges Pompidou, Paris, France|
|Jaroslaw Regula||Institute of Oncology,Warsaw, Poland|
|Douglas-Kevin Rex||University Hospital, Indianapolis (IN), USA|
|Konstantinos Triantafyllou||University General Hospital, Athens, Greece|
|Maria Pellisé Urquiza||Hospital Clínic - Gastroenterology Department, Barcelona, Spain|
|Diana Yung||The Royal Infirmary of Edinburgh, Edinburgh, UK|